Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT02469662
Other study ID # CMU2014-06E
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date June 2015
Est. completion date December 2032

Study information

Verified date April 2023
Source Zimmer Biomet
Contact Richard Marek
Phone 574-453-7567
Email richard.marek@zimmerbiomet.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The objectives of the study are to confirm safety and performance of the Zimmer Nexel Total Elbow when used in primary or revision total elbow replacement.


Description:

The objectives of the study are to confirm safety and performance of the Zimmer® Nexel™ Total Elbow when used in primary or revision total elbow replacement by analysis of standard scoring systems, radiographs, and adverse event records. The safety of the device will be monitored using the frequency and incidence of reporting adverse events. The performance of the device will be evaluated by assessing the pain and functional performance, survival of the device, patient health status, and radiographic success of the implant.


Recruitment information / eligibility

Status Recruiting
Enrollment 120
Est. completion date December 2032
Est. primary completion date December 2024
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Patient is 18 years of age or older. - Patient must have signed Institutional Review Board (IRB)/Ethics Committee (EC)-approved informed consent. - Patient is a candidate for primary or revision total elbow arthroplasty, based on symptoms including at least one of the following: - Elbow joint destruction which significantly compromises daily living activities - Post-traumatic lesions or bone loss contributing to elbow instability - Ankylosed joints, especially cases of bilateral ankylosis from causes other than active sepsis - Advanced rheumatoid arthritis, post-traumatic, or degenerative arthritis with incapacitating pain - Instability or loss of motion when the degree of joint or soft tissue damage precludes reliable osteosynthesis - Acute comminuted articular fracture of elbow joint surfaces that precludes less radical procedures, including 13-C3 fractures of the distal humerus - Patient is willing and able to complete scheduled follow-up evaluations as defined by the protocol. Additional Retrospective Arm Inclusion Criteria - Patient must have undergone a total elbow replacement with the Nexel system between July 2013 and the date of the site initiation visit. - Patient information available for each retrospective patient must, at minimum, include preoperative demographic information, preoperative physical exam information, the index surgery operative report, and details of the devices implanted. Exclusion Criteria: - Patient has a currently active or history of repeated local infection at the surgical site. - Patient has a current major infection distant from the operative site. - Patient has a history of prior sepsis. - Patient suffers from paralysis or dysfunctional neuropathy at the elbow joint. - Patient has significant ipsilateral hand dysfunction. - Patient has excessive scarring near the surgical site, which could prevent adequate soft tissue coverage. - Patient participates in daily activities that may cause significant stress to an implanted device such as heavy labor, torsional stress, and/or competitive sports. - Patient is a prisoner. - Patient is mentally incompetent or unable to understand what participation in the study entails. - Patient is a known alcohol or drug abuser. - Patient is anticipated to be non-compliant. - Patient is known to be pregnant.

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Nexel Total Elbow
Nexel Total Elbow used in primary or revision total elbow arthroplasty

Locations

Country Name City State
Australia Sydney Shoulder & Elbow, NSW Sydney New South Wales
Finland Coxa Hospital Tampere
France Hôpital Purpan (Centre Hospitalier Universitaire Toulouse) Toulouse
Germany Arcus Sportklinik Pforzheim
Italy AO Mauriziano Torino
Netherlands Amphia Ziekenhuis Breda Breda
United Kingdom Wrightington Wigan
United States OrthoCarolina Research Institute Charlotte North Carolina
United States Campbell Clinic Germantown Tennessee
United States Panorama Orthopedics and Spine Center Golden Colorado
United States Rothman Institute Philadelphia Pennsylvania

Sponsors (1)

Lead Sponsor Collaborator
Zimmer Biomet

Countries where clinical trial is conducted

United States,  Australia,  Finland,  France,  Germany,  Italy,  Netherlands,  United Kingdom, 

Outcome

Type Measure Description Time frame Safety issue
Primary Survivorship Based on removal or intended removal of the device and determined using the Kaplan-Meier method 10 years
See also
  Status Clinical Trial Phase
Completed NCT02139345 - TC-A Registration Study N/A
Terminated NCT00872547 - Multi-Centre Study to Assess the Long-term Performance of the DePuy ASR™ System in Resurfacing and Primary Total Hip Replacement Phase 4
Completed NCT00487565 - Clinical Investigation of the LCS® Complete Posterior Stabilized Mobile-bearing Total Knee System N/A
Completed NCT00586781 - Study of the Scandinavian Total Ankle Replacement (STAR) for the Treatment of Bilateral Degenerative Ankle Disease Phase 3
Active, not recruiting NCT03343171 - Continuum Ceramic on Ceramic Bearing Post Market Clinical Follow-Up Study
Completed NCT00503438 - Ankle Joint Replacement Outcomes Study
Terminated NCT00764894 - Foundation Knee Study - Retrospective Phase 4
Terminated NCT00492219 - Postoperative Function Following Partial and Total Knee Replacement N/A
Terminated NCT00208403 - A Randomised Single Centre Study to Compare the Long-term Performance of Acryloc™ and Palacos® R Bone Cements in Primary Total Hip Replacement Phase 4
Active, not recruiting NCT03357445 - AVANTAGE® RELOAD Double Mobility Acetabular Cup -Clinical Study N/A
Completed NCT02574312 - ATTUNE Single-Use Instrumentation vs. ATTUNE Reusable Instrumentation in Primary Total Knee Arthroplasty N/A
Terminated NCT00839020 - Minimally Invasive Versus Conventional Approaches in Navigated Total Knee Arthroplasty (TKA) Phase 4
Terminated NCT00872794 - A Single Centre Study to Assess the Long-term Performance of the DePuy ASR™ System in Primary Hip Resurfacing Surgery Phase 4
Completed NCT00764530 - Cementless Alumina-Alumina Total Hip and Hybrid N/A
Terminated NCT00306917 - Clinical Study Comparing Two Implant Surface Finishes in Patients Undergoing Cementless Total Hip Replacement N/A
Terminated NCT00208351 - A Randomised Single Centre Study to Compare the Long-term Performance of 4 Designs of the DePuy Ultima LX Stem in Primary Total Hip Replacement Phase 3
Terminated NCT01657435 - 28mm Ceramic-on-Ceramic Total Hip Replacement Study
Active, not recruiting NCT01307384 - Zimmer Continuum Metal on Polyethylene (MoP) PostMarket Clinical Followup (PMCF) Study
Completed NCT00872066 - A Study to Assess the Long-term Performance of SmartSet® HV and SmartSet® GHV Bone Cements in Primary Total Hip Replacement Phase 4
Completed NCT00289094 - Randomized Fixed Bearing vs Mobile Bearing Cruciate Retaining TKA N/A